NCT02716012 2025-03-10
OUTREACH
Mina Alpha Limited
Phase 1 Unknown
Clinical Trials
3,104 trialsNCT06216743 2024-12-31
PRE-MISTIC
Radboud University Medical Center
Phase NA Unknown
NCT03310632 2024-09-25
Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer
Golden Biotechnology Corporation
Phase 1/2 Unknown
NCT05625737 2024-09-19
Fruquintinib Combined with Sintilimab As Second-line Therapy for Gastric or Gastro-esophageal Junction Adenocarcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Unknown
NCT05830097 2024-08-26
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Coherent Biopharma (Hefei) Co., Ltd.
Phase 1/2 Unknown
NCT05183243 2024-07-16
GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results
Suzhou Genhouse Bio Co., Ltd.
Phase 1 Unknown
NCT05240625 2024-06-20
Clinical Efficacy Evaluation of a Computer-aided Colonoscopy as Compared With the Standard Colonoscopy.
National Taiwan University Hospital
Phase NA Unknown
NCT05832892 2024-06-14
Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer
Shanghai Zhongshan Hospital
Phase 1/2 Unknown
NCT06270706 2024-06-12
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Pliant Therapeutics, Inc.
Phase 1 Unknown
NCT06435741 2024-05-30
Molecular Imaging of Gastric Cancer Metastatic Lymph Nodes with 99mTc-3PRGD2 Probe.
Peking University Cancer Hospital & Institute
Phase NA Unknown
NCT05605197 2024-05-28
U87 CART in Treatment of Advanced Solid Tumor
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Phase 1 Unknown
NCT01516710 2024-05-10
Oslo-CoMet
Oslo University Hospital
Phase NA Unknown
NCT04159974 2024-05-09
RICE
University of Cologne
Phase 2 Unknown
NCT06405685 2024-05-08
Nimotuzumab Plus AG in Pancreatic Cancer With Liver Metastasis
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT06395337 2024-05-02
MIRCA & MIPAC
Radboud University Medical Center
Phase 1/2 Unknown
NCT06217250 2024-04-18
COWL
Istituto Clinico Humanitas
Phase NA Unknown
NCT06061445 2024-04-12
Radiotherapy Combined With TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular Carcinoma
Fujian Cancer Hospital
Phase NA Unknown
NCT05106244 2024-04-03
RRTGS
First Affiliated Hospital Xi'an Jiaotong University
Phase NA Unknown
NCT06345300 2024-04-03
NALIRIFOX in Combination With Camrelizumab for BRPC: a Prospective, Exploratory Study
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown
NCT06231680 2024-03-29
Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)
Henan Cancer Hospital
Phase 2 Unknown
NCT06335147 2024-03-28
PD1 Antibody Combined With mFOLFOX6 Neoadjuvant Therapy for Advanced Resectable Metastatic Colon Cancer
Henan Cancer Hospital
Phase NA Unknown
NCT06322563 2024-03-21
Combination of LTC004 and Regorafenib to Treat Patients With Advanced/Metastatic CRC
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT05143970 2024-03-20
CHANCES
Institut Paoli-Calmettes
Phase 1 Unknown
NCT04062656 2024-03-12
IMAGINE
University Hospital, Essen
Phase 2 Unknown
NCT06301828 2024-03-08
Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors
Nanjing First Hospital, Nanjing Medical University
Phase 2 Unknown
NCT04780217 2024-03-04
Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors
ImmVira Pharma Co. Ltd
Phase 1/2 Unknown
NCT06289803 2024-03-04
The Application of Probe Confocal Laser Endomicroscopy in Pancreatic Tumor Surgery
Fudan University
Phase NA Unknown
NCT04653181 2024-02-29
PREFECO
Helsinki University Central Hospital
Phase NA Unknown
NCT06280690 2024-02-29
SGM-T1
Leiden University Medical Center
Phase 2 Unknown
NCT06283303 2024-02-29
A Clinical Study of T3011 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer
China Medical University, China
Phase 1 Unknown
NCT06284746 2024-02-29
Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer
Chinese PLA General Hospital
Phase 2 Unknown
NCT04512209 2024-02-28
DCE-MRI
University Hospital, Ghent
Phase NA Unknown
NCT05184803 2024-02-28
A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer
Asan Medical Center
Phase 2 Unknown
NCT05531864 2024-02-28
RCT
The First People's Hospital of Neijiang
Phase NA Unknown
NCT06250166 2024-02-28
Feasibility, Acceptability, and Effectiveness of an Individualized Plant-based (iPLANT) Diet Plan in Colorectal Cancer: Mixed Method Embedded Design
National Cancer Institute, Malaysia
Phase NA Unknown
NCT06281860 2024-02-28
PITHAC
Centre Hospitalier Universitaire Vaudois
Phase 1 Unknown
NCT05122091 2024-02-26
Fruquintinib Plus SOX as Neoadjuvant Therapy for Locally Advanced Gastric Adenocarcinoma
Guangxi Medical University
Phase 2 Unknown
NCT05371223 2024-02-26
Nab-PIPAC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 2 Unknown
NCT06278701 2024-02-26
The Effect of Late-evening Snacks on Patients With Primary Hepatocellular Carcinoma After Hepatectomy
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase NA Unknown
NCT06075849 2024-02-23
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent
Panolos Bioscience
Phase 1 Unknown
NCT05178043 2024-02-22
GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma
Suzhou Kintor Pharmaceutical Inc,
Phase 2 Unknown
NCT04096417 2024-02-21
Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations
Academic and Community Cancer Research United
Phase 2 Unknown
NCT05031325 2024-02-21
Efficacy of a Hemostatic Agent (PuraStat®) in Reducing Delayed Bleeding After Endoscopic Submucosal Dissection
Société Française d'Endoscopie Digestive
Phase NA Unknown
NCT05591053 2024-02-21
Utility and Usability of ActivSightâ„¢ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans
Activ Surgical
Phase NA Unknown
NCT06269445 2024-02-21
The Efficacy and Safety of Lcaritin Combined With Bevacizumab and FOLFIRI in Treatment of Liver Metastases From Colorectal Cancer
Sir Run Run Shaw Hospital
Phase 4 Unknown
NCT06203587 2024-02-20
Clinical Study of GPA33-specific PET/CT for the Diagnosis of Colorectal Cancer
Huashan Hospital
Phase NA Unknown
NCT06210334 2024-02-20
HAI-TL
Eastern Hepatobiliary Surgery Hospital
Phase 2 Unknown
NCT06268106 2024-02-20
Graphic Novel for Patients Undergoing EUS-FNB
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
Phase NA Unknown
NCT02041936 2024-02-16
Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System
University of Maryland, Baltimore
Phase NA Unknown
NCT03924466 2024-02-16
VUBAR
Universitair Ziekenhuis Brussel
Phase 2 Unknown